633 results on '"BRUIJNZEEL-KOOMEN, Carla A."'
Search Results
202. Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis
203. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis
204. The Self-Administered Eczema Area and Severity Index in Children with Moderate to Severe Atopic Dermatitis: Better Estimation of AD Body Surface Area Than Severity
205. Reply
206. The Digital Eczema Centre Utrecht
207. Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
208. Cyclosporin A reduces CD4+CD25+ regulatory T-cell numbers in patients with atopic dermatitis
209. Double-blind, placebo-controlled food challenge in adults in everyday clinical practice: a reappraisal of their limitations and real indications
210. Teledermatologic Consultation and Reduction in Referrals to Dermatologists
211. Throwing a Light on Photosensitivity in Atopic Dermatitis
212. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis
213. Low Bone Mineral Density in Adult Patients with Atopic Dermatitis: Topical Corticosteroids Wrongfully Accused
214. Low Basal Serum Cortisol in Patients with Severe Atopic Dermatitis: Potent Topical Corticosteroids Wrongfully Accused
215. Differential Gene Expression in CD4+ T Cells from Atopic Dermatitis Patients is Due to Selective Expression in the Skin Homing T Cells
216. The tailored implementation of the nursing programme ‘Coping with itch’
217. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy
218. Lipid transfer protein–linked hazelnut allergy in children from a non-Mediterranean birch-endemic area
219. Lupine allergy: Not simply cross-reactivity with peanut or soy
220. Cyclosporin A Treatment Is Associated with Increased Serum Immunoglobulin E Levels in a Subgroup of Atopic Dermatitis Patients
221. The nursing programme ‘Coping with itch’: a promising intervention for patients with chronic pruritic skin diseases
222. Food allergy in the Netherlands: differences in clinical severity, causative foods, sensitization and DBPCFC between community and outpatients.
223. Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of nonhereditary angioedema: a retrospective study.
224. Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity.
225. UVB phototherapy in an outpatient setting or at home: a pragmatic randomised single-blind trial designed to settle the discussion. The PLUTO study
226. UV hardening therapy: A novel intervention in patients with photosensitive cutaneous lupus erythematosus
227. Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children
228. Differential Expression of Genes Involved in Skin Homing, Proliferation, and Apoptosis in CD4+ T Cells of Patients with Atopic Dermatitis
229. In vivo assessment with prick-to-prick testing and double-blind, placebo-controlled food challenge of allergenicity of apple cultivars
230. Decreased Neutrophil Skin Infiltration After UVB Exposure in Patients with Polymorphous Light Eruption
231. Peanut allergy: sensitization by peanut oil–containing local therapeutics seems unlikely
232. Cow's milk–specific T-cell reactivity of children with and without persistent cow's milk allergy: Key role for IL-10
233. Differential Expression of Cytokines in UV-B–Exposed Skin of Patients With Polymorphous Light Eruption
234. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell–attracting chemokine (CTACK) levels in allergic diseasesTARC and CTACK are disease-specific markers for atopic dermatitis
235. Clinical reactivity to hazelnut in children: Association with sensitization to birch pollen or nuts?
236. Evaluation of Impermeable Covers for Bedding in Patients with Allergic Rhinitis
237. Eine revidierte Nomenklatur der Allergie
238. Reply
239. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy
240. IgE to Bet v 1 and profilin: Cross-reactivity patterns and clinical relevance
241. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: The Dutch mite avoidance study
242. Epidermal Langerhans Cell Depletion After Artificial Ultraviolet B Irradiation of Human Skin In Vivo: Apoptosis Versus Migration
243. Cell-surface expression of CD25, CD26, and CD30 by allergen-specific T cells is intrinsically different in cow's milk allergy
244. Cow's milk-specific T cells in non-atopic, non-allergic infants display a reduced-activated Th0 phenotype
245. Allergen recognition patterns in a Dutch hazelnut allergic population in relation to reactivity patterns as observed during double blind placebo controlled food challenges (DBPCFC)
246. Differences in antigen-specific T-cell responses between infants with atopic dermatitis with and without cow’s milk allergy: Relevance of TH2 cytokines
247. Modulation of the atopy patch test reaction by topical corticosteroids and tar
248. Expression of VCAM‐1, ICAM‐1, E‐selectin, and P‐selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis
249. Interleukin 4 and interferon‐γ expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno‐histochemical study
250. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.